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7In this report, we have compared trends in life expectancy in the Netherlands 
to the United States that has a similar pattern, and to Sweden and France, the 
winners in Europe, and to Japan. Japan has had the highest life expectancy at 
birth for more than two decades now, currently approximating 79 years for 
men and 86 years for women. The corresponding life expectancy at birth in 
the Netherlands is respectively 77 and 81 years. In our study we show that 
the observed differences in life expectancy between these countries are 
dominated by mortality after age 65, as mortality at young age has almost 
vanished and death at middle age is minimised. The period of stagnation in 
life expectancy observed in the Netherlands is mainly caused by the fact that 
the rate of mortality in old age has remained constant whereas in other 
countries, most prominently in Japan, has continued to decrease. 
Smoking is an important determinant of mortality in old age. We have 
therefore closely examined the effect of smoking on life expectancy. At age 
65 smoking in the Netherlands shortens life expectancy among men by 3.5 
years and 1.5 years among women. We also calculated life expectancy at age 
65 after correction for different smoking behaviour in the countries under 
study and found that the shorter life expectancy after age 65 of Dutch men 
is by and large attributable to smoking. Among Dutch women of 65 years 
and older, smoking also explains part of the shorter life expectancy, but, 
after correction for smoking, life expectancy remains more than two years 
shorter when compared to Japanese women of the same age.  
It remains to be elucidated why older women in the Netherlands live several 
years less than in Japan. As we show in this report, the increased mortality 
rate cannot be attributed to a specific group of diseases. An emerging 
hypothesis therefore is that more general, societal determinants could 
explain for the shorter life expectancy of Dutch women.
Over the past fifty years, Dutch society has seen major shifts in responsibility 
for care of the elderly. Traditionally, the family and religious institutions took 
care, but this responsibility has almost completely shifted to formal and 
institutionalised care. In this report, we have explored whether this shift in 
Between 1934 and 1964, the Dutch repeatedly 
enjoyed the highest life expectancy in the world. 
Since then, both men and women experienced a long 
period of stagnation and by now life expectancy in the 
Netherlands has been surpassed by many countries. 
It has dropped from its first place position to 
the ninth place in the European Union (EU-15). 
As a longer life expectancy reflects the fact 
that good health is being maintained for longer, 
it is of key importance to better understand 
differences in life expectancy among countries.
Summary
6
8 9
responsibility of care may have contributed to the differences in life expec-
tancy. A widespread idea is that the Netherlands has one of the highest rates 
of institutionalisation in the world whereas Japan has one of the lowest. 
We show that this assumption is only correct on first sight. If we take into 
account the long-term stay in hospitals in Japan, the Netherlands and Japan 
have a similar rate of institutionalisation above age 65. We therefore believe 
that institutionalisation cannot be responsible for the differences in life 
expectancy. Following from this, we concentrated on another striking 
difference between Japan and the Netherlands, namely the responsibility for 
informal care. We put forward two observations. First, in Japan older people 
live far more often with, or in close proximity of their children. Second, we 
have established that in Japan instrumental support is commonly included 
in informal care, whereas in the Netherlands emotional support plays a far 
greater role. It is tempting to speculate that co-residence and the different 
kind of support, may, in part, be the explanation for the differences in life 
expectancy.
In conclusion, this international comparison has shown us that life 
expectancy continues to rise. It is a challenge how to further improve 
outcomes of older people in the Netherlands and to narrow the gap with 
countries that have higher life expectancies. Strategies to discourage the 
habit of smoking in the Netherlands should be intensified and there is no 
reason to lessen attention for smokers above the age of 65. Next, it is 
necessary to continue the falsification of hypotheses that can explain the 
gap between the Netherlands and other countries, and to find positive 
arguments for causal explanations, further extending the healthy years of life.
11
Figure 1 shows the ‘best-performance life expectancy’, i.e. the countries 
with the highest life expectancy from 1850 to the present day. These 
data show that life expectancy has increased with a remarkably steady 
trend by almost 2.5 years per decade and that there is no indication 
yet that the increase in life expectancy is levelling off. 
The Dutch life expectancy trend is plotted in red. A first observation is 
that in 1850 life expectancy in the Netherlands was far below the linear 
trend line. From 1850 onwards however, Dutch life expectancy increased 
at a pace that surpassed the general trend of the countries that were 
leading at the time. From the 1950s through the 1960s, life expectancy 
of women in the Netherlands was among the best of the world. 
For men, the Netherlands performed at top level from 1920 to 1960, 
with World War II being the exception. From the 1960s onwards, the 
Netherlands have not been able to keep up with other countries and 
many have now surpassed us. In the period 2002 to 2004, life expec-
tancy of the Netherlands dropped below average in the EU-15 (the EU 
before accession of ten new members in 2004), to the ninth position of 
fifteen. According to our socioeconomic status, life expectancy in the 
Netherlands is several years shorter than can be expected. 
Life expectancy is a key demographic figure 
as it reflects overall mortality and can be validly 
compared between countries and periods. 
Life expectancy is a sign of the net health 
outcomes of current medical, societal, and 
political structures of all age groups. 
With continuing socio-economic development, 
life expectancy has spectacularly increased 
in all developed countries over the past 
150 years. 
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Figure 1: Life expectancies at birth from 1850 to the present. 
Country with the best performance versus the Netherlands
      women       men
Source: Human Mortality Database 
To investigate the period of stagnation of Dutch life expectancy, this 
report compares Dutch life expectancy to life expectancy in four 
countries: the United States, Sweden, France, and Japan. We selected 
these countries because France and Japan have the highest life 
expectancy in Europe and worldwide, respectively. Sweden is included 
in the comparison because it has a similar socioeconomic history as 
the Netherlands. The United States is included because it experienced 
stagnation of mortality similar to the Netherlands.
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1.1 Epidemiologic transition in the Netherlands
Over the past 150 years, the Netherlands, in line with other developed 
countries, saw a remarkable change in mortality patterns. First, child 
mortality greatly reduced. This marks the transition from a period 
where mortality is determined by epidemics of infectious diseases to 
a period where mortality is predominantly caused by chronic diseases 
at higher ages. This so-called ‘epidemiologic transition’ was followed 
in the second half of the 20th century by a decrease in mortality at 
middle age. Mortality at old age, however, has changed only little, a 
phenomenon that is even more pronounced for men than for women. 
This stagnation of ‘mortality decrease in old age’ is peculiar, and the 
Netherlands clearly stands out in this respect, as in other developed 
countries mortality at higher ages did significantly decrease. The 
latter observation strongly argues against the common idea that 
mortality in old age is fixed and cannot be positively influenced. 
In this chapter, we describe the changes in 
mortality and life expectancy in the Netherlands 
and compare these trends to those in 
the United States, Sweden, France, 
and Japan.
1. Trends in life expectancy
Box 1. Cohort and period life expectancy
No demographic measure is so often misquoted and misunderstood as 
life expectancy. We can define two types of life expectancies: cohort life 
expectancy and period life expectancy. A cohort life expectancy is the 
true life expectancy of a cohort born in a certain year, e.g. all the people 
born in 1900. This cohort life expectancy is only known for sure in very 
old cohorts, who have all passed away or are close to dying. In 1900, 
the cohort life expectancy in the Netherlands was 55 years. 
What is commonly used in health policy is period life expectancy. In 
1900, the period life expectancy in the Netherlands was 48 years, not 
less than seven years lower than the cohort life expectancy. The period 
life expectancy summarises all age specific death rates of a single 
period (in this case the year 1900). Among the population of 1900, the 
mortality was much higher than among the birth cohort of 1900, which 
will be subjected to the mortality of 1900-2010 (if we ignore the few 
16 17
Figure 2: Survival probabilities of women and men in the Netherlands 
in 1850, 1900, 1950, and 2008
      women
      men
Source: Human Mortality Database
Figure 2 presents the estimated survival probabilities of women and 
men born in 1850, 1900, 1950, and 2008, assuming that age-specific 
mortality would not have changed over their lifetime. 
Before 1950, survival probabilities at young ages improved for both 
boys and girls. This becomes apparent if one compares the curves of 
1850 and 1900 at young ages. At that age, mortality has simply 
vanished. Next, between 1950 and 2008, survival probabilities in 
middle age have approached 100 percent, an indication that mortality 
in middle age has decreased considerably. It is generally accepted that 
this benefit mainly results from a 80% decrease in death from coronary 
heart disease in this age group. Nowadays survival probabilities up to 
age 65 amount to approximately 86% for men and 90% for women. 
Finally, the shift to the right, although moderate, of the survival curve 
is due to the decreased mortality risk in old age. Mortality now concen-
trates itself on higher ages and this results in a curve shift to the right 
in the figure, meaning that mortality not only concentrates itself at old 
age, but also at continuously higher ages. The lagging behind, as 
compared to other countries, or phrased otherwise, the inability of the 
postponement of old age mortality needs to be explained.
that reached the age of 110 or above). A period life expectancy is a 
mean age at death of a distribution with (historically) two modi: one in 
infancy and one at old age. The low life expectancy of earlier periods, or 
of low-income countries today, means that many children die. In 1900, 
the period life expectancy at birth (age 0) was 48 years old, but at age 1 
this was already 57 years. In the period life table, the cohort life 
expectancy at age 1 in 1900 was 65 – close to 70% would reach the age 
of 65 in 1965. During this period, this would be but slightly more than 
50%. That is because the ‘synthetic’ period life table cohort is subjected 
to the mortality of 1900.
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Figure 3: Trends in life expectancies at birth from 1950 onwards 
      women
      men
Source: Human Mortality Database
The shape of the survival curve has led to an intensive scientific and 
socio-political debate. The discussion was initiated in the early 1980s 
with a seminal paper on the ‘compression of mortality’. The central 
idea was that disease at a young and middle age could be prevented 
well, whereas mortality in old age was not accessible to intervention 
and lifespan was therefore limited. This is a highly attractive hypothe-
sis from a socio-medical as well as an economic point of view. Once 
diseases are successfully dealt with, one would survive in good health 
until death limits the human lifespan and everyone would die quickly. 
This hypothesis is false on various grounds. First, insights into the 
biology of ageing strongly argue against a ‘fixed’ lifespan. Second, 
there is a continuous increase in the maximum age at death, the 
present record being 122 years. Third, observational data on mortality 
in old age show a significant decrease in various countries. Fourth, 
survival patterns in developed countries, the Netherlands included 
(see figure 2), show a shift to the right in mortality. The overall 
conclusion is that we can delay death to a higher age and therewith 
successfully increase the length of life.
1.2 An international comparison
Over the last few decades, life expectancy has increased in virtually 
all developed countries. It decreased only as a consequence of a 
socio-political system collapsing as witnessed, for example, in Russia 
in the 1990s. However, life expectancies at birth differ considerably 
among developed countries and also the pace at which they increase. 
Figure 3 shows the secular trends of life expectancy for women and 
men in five developed countries over the past 50 years. In the 1950s, 
life expectancies at birth were high in the Netherlands and Sweden. 
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In the last few decades until around 2002, however, due to a period 
of stagnation, life expectancy in the Netherlands has not improved as 
much as it has in other countries. Many nations have now surpassed 
us, leaving the Netherlands, the country with the highest life expec-
tancy in the 1950s, in 2006 at the 14th place among the economic 
developed countries (OECD). 
1.3 The achievements of Japan
The achievements of Japan are extraordinary. In the 1950s, lifespan 
at birth in Japan was considerably shorter than in other countries. 
This was not a direct effect of war, as it is not essentially different 
from the situation in the 1930s, and ensuing from the socioeconomic 
and political structures at the time. The very rapid increase in life 
expectancy is the result of a massive decrease in mortality at the 
time when post-war Japan became an economic power, changing its 
socio-political structures. The net result is that Japan has enjoyed 
the highest life expectancy in the world over the last two decades. 
Apart from the overall increase in financial means, it is yet unknown 
whether there are specific factors that contribute to the increase in 
life expectancy. It is intriguing to see that all this happened despite 
the imprint that an affluent lifestyle left on the causes of death in 
Japan. Mortality risk at all ages decreased considerably but among 
those who died, coronary artery disease, lung cancer, and suicide 
which were virtually unknown causes of death in earlier days, have 
now become a frequent and fatal disease. If we can understand the 
factors behind Japan’s performance it could give us an understanding 
of how to improve life expectancy in the Netherlands.
Box 2. Zooming in on the latest figures
Recently, a short report was published about a rapid increase in life 
expectancy in the Netherlands since 2002. The figures in this box show 
this specific increase for males and females from 2002 onwards. Both 
life expectancy at birth and life expectancy at age 65 show a period of 
increase in life expectancy. The previous period of relative stagnation is 
clearly present for women. It seems that the males started to improve 
their life expectancy already earlier; approximately since 1985. This 
indicates that trends in life expectancy are very susceptible to periodic 
changes, although the specific factors influencing life expectancy 
remain unclear. 
Source: OECD
The figure on the left shows Dutch life expectancy at birth for males and 
females 1980-2009 in the Netherlands. The right figure shows Dutch 
life expectancy at age 65 for males and females for the same period. 
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Figure 4: Trends in life expectancies at age 65 from 1950 onwards
      women
      men
Source: Human Mortality Database
1.4 Life expectancy at birth reflects differences in   
 mortality at higher ages
As in developed countries mortality at young and middle age has 
come to a minimum, differences in life expectancy are now mainly 
caused by mortality differences in old age, close to all mortality is 
is found among the older people as one can in see figure 2. It is 
therefore vital to examine life expectancy at age 65, i.e. the number 
of years people can expect to live when they have reached the age 
of 65. In Figure 4 it becomes especially clear that there is a different 
trend in the Netherlands, similar to the United States. Both curves 
start relatively high but compared to other countries the slope is 
rather modest and after 1980 an increase is almost absent, especially 
for women. For the Netherlands, a clear period of relative stagnation 
can be seen until 2002. This period of stagnation is caused by the 
fact that the rate of mortality in old age remained constant whereas 
in other countries, most prominently in Japan, it continued to decrease. 
As a result, at age 65, life expectancy in the Netherlands is nowadays 
three years shorter for women and two years for men when compared 
to Japan. While, if one would compare this to the situation in the 
1950s, these results would be exactly the other way around.
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Figure 5: Life expectancy and healthy life expectancy 
in the Netherlands
      women
      men
Source: CBS Statline
1.5 Life expectancy and healthy life expectancy in 
 the Netherlands
Life expectancy at age 65 in particular reflects outcomes of the 
socio-medical systems to prevent and cope with chronic, age-associated 
diseases. This is illustrated in Figure 5, which shows both life expec-
tancy and three different forms of healthy life expectancy in the 
Netherlands over the past thirty years. The three lines at the top 
clearly show that the gradually longer life span is associated with 
longer lives in good self-rated health and longer lives without disabi-
lities. Over the past decennia, the number of years without chronic 
diseases is decreasing. This is mainly because chronic diseases 
include high blood pressure, but also because active and passive case 
detection is moving diagnosis to an earlier age. Added to this is the 
effect of the lowering of clinical thresholds of disease, often caused 
by available treatment (e.g. hip replacement). At least part of our 
longer lives is therefore exactly brought about by increased case 
detection and increased medical treatment of risk factors. The 
positive effects of which can be seen in the increase in life expec-
tancy and good self-rated healthy life expectancy, simultaneously 
these increases come with a decrease in life expectancy without 
chronic diseases. The positive conclusion is thus that our socio-
medical system not only makes people live longer but also extends 
the number of years in self-rated good health and in active years 
without disability. The grimmer part of this observation is that we 
have not yet been able to limit the number of years with disabilities 
at the end of life.
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Given these data, what health messages can be drawn? The extended 
observations on lifespan and health span outlined above allude to 
general phenomena that are not exclusive to the Netherlands. It 
emphasizes that there are various ways to live a longer healthier life. 
First, it is essential to prevent chronic, age-associated diseases such 
as atherosclerosis, diabetes and dementia. Here is an important role 
for public health strategies to prevent smoking, hypertension and 
obesity, by improving the quality of our diet, and by increasing the 
level of exercise. Second, it shows the importance of screening and 
diagnostic strategies for chronic age-associated diseases to minimize 
persistent complications and disabilities at the earliest time. Although 
early detection could suggest that more years are spent with disease, 
early treatment prevents late-life complications, explaining the 
paradox of increasing life expectancy without disabilities with 
decreasing life expectancy without disease. Third, optimising cure 
and care for those with disabilities enables the maintenance of high 
self-rated health, quality of life and the length of their lifespan.
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Life expectancy in the Netherlands has not 
improved as much as in other developed countries. 
This is mainly driven by mortality differences in 
old age. What caused this stagnation of mortality 
decline in old age?
2. A period 
2.1 Common explanations
Earlier studies have put forward various explanations for the relatively 
long period of stagnation in Dutch life expectancy. The first explanation 
is that it is a consequence of the high life expectancy that the Dutch 
enjoyed in the middle of the last century. Mortality at young and 
middle age was relatively low and people were comparatively well off. 
The frail, the sick, and those with disabilities had relatively high 
survival probabilities, up to old age. Due to these, so-called cohort 
effects or selection, the present day survivors from these earlier 
periods now experience excess mortality in old age. Sweden has seen 
similar patterns of low mortality in the last century, in contrast to the 
Netherlands though life expectancy in Sweden has continued to 
increase over the past 50 years. A cohort effect or selection is there-
fore unlikely to be the cause of the Dutch stagnation. An alternative 
explanation that takes the comparatively welfare in the 1950s in 
account is the hypothesis that this would have led to acceleration 
instead of stagnation of life expectancy. The reasoning would then be 
that those who lived under relatively prosperous conditions have 
accumulated less damage, have suffered fewer disabilities, and have 
better survival probabilities, but this is not the case in the Netherlands. 
The scientific debate on this dispute is as yet unresolved.
A second explanation put forward is the reasoning that economic 
development, Japan a prime example in this context, drives the 
increase in life expectancy and that residual differences in economic 
development are the cause of the dissimilarities in life expectancy. 
Economic development is an important determinant of socio-medical 
progress and largely explains the difference in life expectancy between 
developed and developing countries. Among developed countries, 
however, international comparisons do not show this strong associa-
tion of development and life expectancy as shown in figure 6 which 
compares the Gross Domestic Product (GDP) per capita, taken as 
indicator of their development and their life expectancy. 
of stagnation
30 31
Figure 7: Gross national product and health expenditure
Source: WHO Health Statistics
Figure 6: Life expectancy and GDP per capita
Source: Gapminder (various sources)
Also, when focusing on indicators of health expenditures per se, 
there is no direct relation between investments in health care and life 
expectancy in developed countries as shown in figure 7. Japan even 
manages to have the highest life expectancy with relatively low 
health-related expenses.
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2.2 Smoking
Another explanation is that smoking causes the stagnation of 
life expectancy in the Netherlands. Smoking is an important risk 
factor for cardiovascular disease and various forms of cancer. 
Since smokers have a life expectancy that is a decade shorter than 
non-smokers, differences in smoking behaviour might well explain 
the observed differences in life expectancy between countries. 
Previously, two studies have been published on the effect of smoking 
on Dutch life expectancy with contradictory results; one study 
reported that smoking did explain the stagnation of the Dutch life 
expectancy, while the other study reported that only part of the 
stagnation was explained by smoking. To come to a more conclusive 
answer on the effect of smoking in the Netherlands and especially 
when compared to other countries, we performed an in-depth study 
of the effect of smoking on mortality in old age. 
To study both the immediate and the late effect of smoking on life 
expectancy, next to current smoking behaviour, historical smoking 
trends should be taken into account. Smoking increases mortality 
via a direct effect on the vasculature and clotting mechanism. 
However, most detrimental effects of which atherosclerosis and 
cancer are the principle ones, only occur after a prolonged period 
of time. To estimate historical smoking behaviour in the different 
countries we adopted a method that makes use of lung cancer 
mortality. 
A third explanation that is often put forward argues that the high 
rate of euthanasia in the Netherlands compared to other countries 
explains the higher mortality rate in older people. However, the 
absolute number of people who undergo euthanasia is low, the latest 
data state 2.636 reports in 2009, 2% of the total number of deaths in 
the Netherlands. Also, euthanasia is only practiced at the very end of 
life when the remaining life expectancy of these individuals is very 
limited. In 2005, for those persons choosing euthanasia – defined 
as the prescription, providing or administering of a means with the 
explicit target of quickening the point of death by a physician - their 
lives were on average shortened by 11 days. Taking into account 
the low relative impact and limited shortening of life expectancy, 
the effect of euthanasia on overall life expectancy is negligible and 
cannot explain why life expectancy from 65 years onwards in the 
Netherlands is considerably shorter than in other developed countries. 
 
A fourth broadly phrased hypothesis claims that specific dietary 
habits explain the differences in life expectancy. To date, however, 
none of these dietary theories has been able to fully explain the 
observed differences in life expectancy. Recent research has shown 
that many classic risk factors of mortality and/or morbidity at middle 
age might be valid for this age group, but these cannot be associated 
with higher mortality rates in higher age groups. High cholesterol, 
for example, explains a large burden of disease at middle age, but 
cannot be associated with increased mortality at higher ages. Also 
optimal body mass index at older ages is above 25 kg/m², which 
would be considered obese in adults.
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The expected smoking prevalence for men is shown in Table 1. 
Smoking was prevalent among men in all countries. Sweden is an 
exceptional case, because tobacco was traditionally chewed there, 
instead of smoked (‘snus’). Chewing tobacco has fewer negative 
effects than smoking tobacco. The expected smoking prevalence, 
based on lung cancer mortality, is therefore lower. The Netherlands 
stands out as a country with high expected historical smoking 
prevalence. The life expectancies corrected for smoking are also 
presented in Table 1. In men, differences in life expectancy between 
countries are largely caused by differences in smoking behaviour; 
the initial difference at age 65 of 2.6 years between France and the 
Netherlands is after correction 0.6 and the difference with Japan 
decreased from 1.7 to 0.8. Although the pattern –with the highest life 
expectancy in Japan and the lowest in the Netherlands and Sweden– 
also corrected for expected smoking behaviour, persists.
Table 1. Expected smoking prevalence and life expectancy of men 
aged 65 in 2005. Expected smoking prevalence is derived from lung 
cancer mortality.
Data: calculated from data from the WHO and the Human Mortality Database (see for more information 
the references and justification) using the method described in Peto et al. (1992)
Table 2 shows the expected smoking prevalence for women. In 
women, smoking was rare in France and Japan. Smoking was most 
prevalent in women in the United States. In the Netherlands and 
Sweden during these periods, women also smoked, but not as much 
as women in the United States. 
Box 3. Expected smoking prevalence
The smoking related mortality in a population is dependent on many 
variables, of which the most important are the number of smokers 
(prevalence), the amount smoked (often expressed as pack-years), the 
age of starting smoking and, if applicable, the age of quitting smoking. 
Smoking prevalence, per se, is but a poor proxy of smoking exposure 
as the effect of smoking is heavily dose dependent. Peto et al. (1992) 
developed an elegant method to assess the impact of smoking, using 
lung cancer mortality as a biological proxy of smoking exposure. In 
developed countries, lung cancer is a very rare disorder among 
non-smokers – persons who have never smoked - but very common 
among smokers. The difference between the lung cancer mortality of 
non-smokers and the observed lung cancer figures in a population is 
then an aggregate measure of tobacco exposure, to be treated as a 
population attributable risk. By assuming the risk ratios of the large 
American Cancer Society, Cancer Prevention Study II (ACS-CPS II), the 
model developed by Peto et al. calculates the smoking prevalence 
expected in that ACS-CPS II study that would cause this population 
attributable risk of lung cancer mortality. This expected prevalence is 
then used to calculate the population attributable risks of other smoking 
related causes of death by applying the risk ratios of the ACS-CPS II 
study to this population attributable risk and the absolute mortality 
rates in the studied population. The sum is the mortality attributable 
to smoking. A more detailed explanation of the methods of this analysis 
can be found in the chapter ‘References and justification’ at the end of 
this report.
Expected smoking prevalence at age 65-74
Expected smoking prevalence at age 75 +
Life expectancy at age 65 
Life expectancy at age 65, corrected for smoking
United States
44%
38%
17.2
20.3
France
36%
27%
18.0
20.4
Netherlands
48%
51%
16.4
19.8
Sweden
21%
18%
17.4
18.9
Japan
26%
41%
18.1
20.6
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lity is attributable to smoking. In the Netherlands, a considerable part 
of the mortality is caused by smoking in women in this age category. 
Figure 8: Mortality rates for different causes of death of women 
aged 65-74 in 2005
     women
Source: WHO Health Statistics
The mortality from all other categories than smoking is similar in the 
Netherlands, United States, Sweden and France, all four being higher 
when compared to Japan. Women in Japan still have the highest life 
expectancy, also when corrected for smoking.
When mortality related to smoking behaviour is estimated as was 
done above, it is possible to study the relative differences in the 
causes of death among the countries, corrected for mortality caused 
by smoking behaviour. Figure 9 shows these relative mortality 
differences in women aged 65-74 compared to Japan for different 
Table 2. Expected smoking prevalence and life expectancy of women 
aged 65 in 2005. Expected smoking prevalence is derived from lung 
cancer mortality.
Data: calculated from data from the WHO and the Human Mortality Database (see for more information 
the references and justification) using the method described in Peto et al. (1992)
It is clear that the low life expectancy of women in the United States 
is largely attributable to smoking behaviour. The differences in life 
expectancy between countries, however, cannot be fully explained 
by smoking alone. Also, when corrected for expected smoking 
behaviour, life expectancies for women in all four countries remain 
lower than in Japan and this residual difference is more pronounced 
in the Netherlands and Sweden. This residual deficit is present among 
women over age 65, the differences with Japan after correcting for 
smoking is 2.6 years indicating that other factors play a role here. We 
conclude that for men expected smoking prevalence probably largely 
explains the differences in life expectancy, but for women these 
differences are not explained by expected smoking prevalence alone. 
Below we start exploring possible additional explanations for diffe-
rences between countries in life expectancy for women.
Figure 8 zooms in on the different causes of death of women in the 
five countries under study. From this figure it becomes clear again 
that the differences in smoking behaviour indeed explain a large part 
of the differences between countries in life expectancy of women of 
this age group. Women in the United States experience a great deal of 
mortality from smoking, while in France and Japan, almost no morta-
Expected smoking prevalence at age 65-74
Expected smoking prevalence at age 75 +
Life expectancy at age 65 
Life expectancy at age 65, corrected for smoking
United States
53%
38%
19.9
22.4
France
8%
5%
22.0
22.3
Netherlands
33%
16%
20.0
21.3
Sweden
27%
14%
20.6
21.6
Japan
8%
17%
23.2
23.9
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causes of death. When we compare the Netherlands to Japan after 
correcting for smoking, there is not one group of diseases that 
explains why Japanese women have lower death rates. Instead, in all 
groups of causes of death Japanese women have lower mortality and 
there is not a single group of diseases that explains the residual 
difference in life expectancy. An additional observation is the slightly 
lower cancer mortality rate in the United States, of which the cause is 
unknown. In France, women experience lower mortality from cardio-
vascular disease. This is known as the Mediterranean paradox: 
countries in southern Europe, even though their diet is rich in fatty 
foods, have low mortality from cardiovascular disease. 
Figure 9: Mortality rate ratios for different causes of death, of woman 
aged 65-74 in 2005 corrected for smoking.
     women
Source: WHO Health Statistics, * Cancer excluding lung cancer
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A first observation is that after correcting for smoking, residual 
differences in life expectancy are larger in women than in men. 
A second observation is that no single disease or group of diseases 
explains the differences in life expectancy among developed coun-
tries. In Dutch women mortality from all groups of diseases is higher 
than in Japan. From this observation it can be deduced that any quest 
to explain the differences with specific medical explanations is un-
likely to bring the right answer. It is not expected that, for instance, 
the occurrence or differences in the treatment of cancer or cardio-
vascular diseases will fully explain the observed differences.
In this chapter, we will first describe the historical changes in the 
Netherlands since the 1950s. Did the Netherlands follow a different 
trajectory compared to other developed countries? After describing 
the historical background, we hypothesise that some of these broader 
societal changes could have led to the current stagnation in Dutch life 
expectancy of women at more advanced ages. 
3.1 Dutch historical background
In the 1950s, the Dutch society was strongly divided into different 
segments known as pillars (‘verzuiling’), according to different 
religions or ideologies. The three largest pillars were the Roman 
Catholic, Protestant, and social-democratic pillars. These pillars 
functioned as completely independent sub-groups and all had their 
own social institutions: schools, political parties, universities, unions, 
sport clubs, and newspapers. These pillars were also responsible 
for many societal tasks that are nowadays considered to be formal 
responsibilities of the government. Each pillar took care of people 
in almost every aspect of life. Regarding health a pillar had a full 
structure of care, from midwives and community nurses to entire 
hospitals. Also, the strong feeling of commitment within each pillar 
created a large network of informal caregivers in the immediate 
In the previous chapter, we have seen that 
smoking behaviour is an important determinant of 
life expectancy and explains a large part of the 
differences among developed countries. In the case 
of the Netherlands, however, smoking behaviour 
of women explains only part of the stagnation 
in life expectancy. What other determinants are 
causing the stagnation in life expectancy in old age 
in the Netherlands?
3. Learning from the best
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Figure 10 shows figures of the OECD on the proportion of people 
above the age of 65 who live in long-term care facilities. The propor-
tions differ widely between the countries. In this comparison, the 
Netherlands has one of the highest rates of people living in institutions 
together with France and Sweden. Other western countries have lower 
levels of institutionalisation and Japan in particular, has very few 
older people in nursing homes or residential homes. Even when 
compared to other countries of the OECD, the Netherlands stands out 
as a country with a very high level of institu-tionalised care for its 
older inhabitants. 
Figure 10: Long Term Care Recipients % of total aged 65 years and 
older, 2004
Source: OECD Health Data, * Data for France are from 2003, ** Data for United States are an estimate 
environment of sick and older people. The intellectual revolution of 
the sixties resulted in strong secularisation and, as a consequence, 
a loss of the integrated sub-system in all pillars of the Dutch society. 
Within an exceptional short period, the Netherlands transformed 
itself from a society where care of sick and older people was the 
primary responsibility of the family and religious or socio-political 
institutions into a society where the prime responsibility for care of 
older people has been transferred to governmental or public institu-
tions. Traditionally, older people lived either together or close to 
their families and formed networks. Increased individualisation and 
migration have, to a large extent, broken down these informal care 
networks. 
The shift from an informal care network due to increased migration, 
secularisation and individualisation, is not something unique to the 
Netherlands. Many other countries experienced similar societal 
changes but sometimes at a different pace and to a lesser extent. 
It is therefore interesting to study the effects of these changes on 
older persons wellbeing and informal care.
Is it perhaps possible that the shift in accountability for the care of 
older people has contributed to the stagnation in life expectancy? 
Nowadays the strong commitment of family-associated informal care 
networks have been replaced by a system in which responsibility has 
been transferred to institutionalised care, either in the form of 
professional in-home health workers or in the form of large scale 
institutionalised care in residential homes or nursing homes. Note 
here that to fully replace a family member who lives together with an 
older person, there is a need for more than four full-time employed 
professional health workers. It needs to be explored whether the 
formal and institutionalised responsibility for dependent and frail 
elders is less beneficial than a familial commitment in a less institu-
tionalised society. If so, there is a clear challenge to improve the 
outcomes of current care.
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Estimates are that the average visit takes about 8 minutes, some even 
claim 3 minutes, and the Japanese health ministry has now installed a 
policy in which visits that take less than 5 minutes can no longer be 
charged. More importantly, the average length of stay in hospitals is 
more than three times as long as the OECD-average reflecting the 
so-called ‘social hospitalisation’ that is actually in place:
Table 3. Health Indicators Comparison Japan, OECD Average and 
The Netherlands 2008
Data: OECD Health Data 2009, * 2001 most recent year available, ** non-existent category in the 
Netherlands, *** 2007 most recent year available
Using the term social hospitalisation seems counterintuitive for the 
case of Japan. It is after all a common assumption that due to the 
‘collective’ spirit of Japanese society and the importance of filial piety 
(oyakoko), the institutionalisation rate of Japan is low. This common 
myth mainly stems from two facts: first of all, rates are usually based 
on the prevalence of long term care institutes in Japan and elderly 
living in nursing homes, and secondly, the myth finds support in the 
high rate of elderly living with family. 
The OECD rates for institutionalisation, already presented in the 
previous paragraph, show that in 2008 2.9% of older people lived in 
long-term care facilities in Japan, compared to a rate of 6.7% in the 
Women more often live in institutionalised care facilities than men 
because women are more often widowed. This is not only because 
they have a longer life expectancy, but also because they traditionally 
marry men who are several years older. 
It remains to be studied in more detail whether the shift in res-
ponsibility for care of older people together with the emergence of 
institutionalised care is a key to understanding the differences in life 
expectancy. We therefore continue this study with a more in-depth 
overview of the Japanese healthcare system and then compare these 
indicators to the Dutch outcomes.
3.2 Institutionalised care in Japan
Healthcare in Japan is mainly paid by a fee per service system. 
There are both private and public hospitals in Japan that are open 
for everyone. There are many hospitals in Japan and on average each 
hospital owns around 20 beds (see table 3). All hospitals should be 
non-profit and owned by either a medical doctor or by a corporation 
of physicians. A similar system is in place for pharmacies of which 
many are (indirectly) owned by physicians. Physicians’ incomes then 
are mainly derived from these two sources.
The payment system combined with physician owned hospitals have 
given incentives to physicians to first of all aim for quantity instead 
of quality (more patients means more income), and second, they, 
for similar reasons, prescribe more medications per visit on average. 
More specifically, the number of doctor consultations in Japan is 
three times as high as the OECD average (see table 3). Also the 
average number of medications is well above OECD average (5 
compared to 2 prescriptions on average per physician visit) whereas 
the average length of a patient visit is short (75.8% of patients spent 
less than 9 minutes per average visit with a physician in 2005). 
Number of hospital beds per 1000 population
Average length of hospital stay (days)
Number of long-term care beds per 1000 population
Number of hospitals per 1 million persons
Total pharmaceutical sales/capita US$ PPP
Doctors consultations per capita
Japan
13.8
33.8
2.8
68.9
445
13.6***
OECD Average
5.6
10.3
1.0
30.8
373
6.8***
The Netherlands
4.3
12.5*
0**
11.1
360
5.7***
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Not only is the average stay in Japanese hospitals exceptionally long, 
but Japanese hospitals also cater more for long-term stay than Dutch 
hospitals. About 20% of the beds in hospitals are meant for long-term 
care, in contrast to Dutch hospitals where such beds are non-existent 
(see table 3). In the Netherlands, older patients are transferred to 
institutions such as residential homes or nursing homes after a short 
stay in a hospital.
Other scholars have also remarked this difference. Tatara & Okamoto 
summarise the matter comprehensively: “Japan has been reliant more 
on hospitals and less on social services for long-term care. This 
imbalance may be explained by the difference in financing system, in 
which hospitals are financed by health insurance while social services 
are financed by taxation. Being financed by taxation, social services 
have consistently been restrained by budget and occasionally subject 
to means testing. From the viewpoints of family caregivers, putting 
the disabled elderly into hospitals involved less social stigma than 
putting them into welfare homes for older people, such as nursing 
homes. Consequently, Japan’s geriatric hospitals came to serve as 
quasi-nursing homes, and the number of geriatric hospitals increased 
to cater for the growing demand generated by population ageing”. 
Hospitals, in short, function to a high degree as long-term care 
facilities for elderly in Japan. The incentive for this practice is not 
solely financial, but there is also a shortage of places in nursing 
homes and consequently long waiting lists for these places. 
Adding up the 3.0% of older people that live in a nursing home (2005)
and the rough estimate of 3.78% of older people that have a prolonged 
stay in a hospital, one arrives at 6.78% just 0.22% below the Dutch 
percentage of older people that live in institutions in 2005. Although 
we assume that not in all cases social hospitalisation is taking place, 
still we can rather safely assume that the rate of institutionalisation is 
not extraordinary below the rate of the Netherlands, if one takes into 
account all kinds of institutions (see also the ILC report “profile of 
Netherlands (65 years and older). This rate, though, we argue is 
deceiving as it does not take into account another distinctive charac-
teristic of the Japanese healthcare system: the long average length of 
stay in hospital. The institutionalisation rate looks rather different if 
we take this into account.
In Japan, in 2005 the number of in-patients per day amounted to 
1.391.600 per day and 71.200 in medical clinics, 64% of those 
patients were above 65 and 43.6% of those patients were above 75 
years old. This means that from the total population of 65 years and 
older in Japan at any day 3.8% of them were in a hospital or a medical 
clinic. That these patients indeed stay relatively long is indicated by 
the average length of stay for the age-group 65 and older in 2005 
which was 50.8 days and only rising for higher age-groups as is 
shown in table 4.
Table 4. Average length of stay in days in hospital in Japan 
(2002 and 2005)
Data: Ministry of Health and Welfare Japan
Age-group
65-69 (2002)
70-74 (2002)
75-79 (2002)
80-84 (2002)
85-90 (2002)
90 and above (2002)
Regrouped 65 and older (2005)
Regrouped 70 and older (2005)
Regrouped 75 and older (2005)
Average length of stay (days) in hospital
44.2
43.9
46.4
53.5
67.8
106.4
50.8
52.5
56.9
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Figure 11: Percentage of people above age 65 living alone
Source: OECD, living alone means a one-person household
Clearly, in Japan both women and men live alone less often than in 
the Netherlands. This is already an indication that familial care might 
play a larger role in Japan than in the Netherlands. However, to 
investigate our second hypothesis, namely whether the responsibility 
for care of older people might be accountable for Japan’s outstanding 
record, we need to expand our study of Japan. We must look more 
in-depth towards the situation of older people in Japan and the 
Netherlands, for which we therefore present two case-studies below.
older Japanese 2010”). In conclusion, Japan seems to be just 
a fraction below the average institutionalisation rates of OECD-
countries such as the USA, Sweden and the Netherlands. The above 
considered, we do not see differences in institutionalisation as the 
key to understand the differences in life expectancy, and this, as 
such, as the source of Japan’s outstanding record. 
3.3 Responsibility for Care
Yet another demographic difference is the living arrangements 
of older women (and men) in the countries under study. The living 
arrangements might influence the care network of older women. 
Figure 11 shows the number of men and women who live alone in 
the different countries. Japan stands out because people over 65 do 
not live alone as often as in western countries. This may reflect the 
traditional role that children and other family members have in Japan 
where older people enjoy high social status and care is a familial 
responsibility.
Legend
men
women
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Box 4. Being old in Japan and in the Netherlands
Japan, Mrs. W. is an 86-year old woman living in a residential suburb 
about 20 kilometres from the centre of Yokohama. She has one son and 
he and his wife have three children. They live about 200 metres from 
Mrs. W.’s house. Her house is conveniently located with a supermarket 
500 metres from her house, her general practitioner about one kilo-
metre away, a bus stop close-by and the hospital at two kilometres 
distance. She is reasonably mobile: she uses a cane to walk and uses 
a bed stick to get out of bed - as a result of a fall last year that was 
caused by heart failure. With these means she is still independent and 
lives alone. She feels her health has deteriorated since her heart failure 
but she is quite healthy for her age with some hypertension, osteoporo-
sis and osteoarthritis and a BMI of 20.6 kg/m². She still walks to her 
son’s house and to shops close-by, but takes a taxi for longer distances 
or uses home delivery. She enjoys visiting her grandchildren. Her three 
grandchildren also visit her quite regularly (almost daily for short visits) 
and help her with some things such as clipping her toe nails, putting out 
the garbage and airing the bed clothes. Her son and his wife help her 
out with heavier tasks such as closing the typhoon shields. Other help 
comes from a home helper (once a week for cleaning) and a gardener 
(3 times a year).
The Netherlands, Mrs. F. is an 85-year old woman living in a village 
about three kilometres of the city of Leiden. She has five siblings, of 
whom four are still alive. Her two daughters live a few kilometres from 
her place. Her house is comfortably located on top of a medium sized 
shopping complex with an array of shops and services, close to the bus 
stop, park and within about two kilometres from the hospital. Since her 
husband died 11 years ago she lives alone. She is unable to walk more 
than a couple of metres because of osteoporosis and pain. Next to this 
she has irritable bowel syndrome and hypertension reducing her 
mobility somewhat further. She has a BMI of around 25 kg/m². She used 
to be quite active and played tennis until age 75, but now she uses a 
rollator to walk short distances outside and relies for further distances 
on her car. Since she has a two-storey apartment she uses a stair-lift to 
go to her bedroom. Her daughters alternately visit her weekly and she 
eats at her oldest daughter’s place every week. Her grandchildren visit 
her regularly and she has a neighbour who is also her best friend whom 
she sees daily. Other friends she sees more sporadically. She is, despite 
her decreased mobility, largely independent and has a strong will to 
remain independent and do things herself: she is still capable of doing 
small housekeeping chores, cooking, shopping and washing and she 
visits an acupuncturist and a beautician regularly. She is helped in her 
housekeeping by her daughters (alternately once a week) and she has a 
formal help for 5 hours every two weeks. 
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The case-studies show at first sight many resemblances: two rather 
healthy older persons receiving both modest amounts of informal 
and formal care. On closer look the differences become apparent: 
Mrs. W. from Japan seems to receive more frequent visits from her 
family and she seems to receive more functional help from especially 
her grandchildren. The element that stands out in the comparison of 
these short case-studies is the responsibility for care which seems to 
rely more on family members and the frequency of social contact in 
the Japanese case. In the Netherlands, Mrs. F. described that she did 
not, nor did she expected or wished to, receive functional, especially 
physical, help from her children. However, this element needs to be 
looked at in greater context to come to any kind of inference of 
causes for differences in life expectancy.
Considering the effect of social relations and support it is well 
known that isolation increases the mortality risk in all causes of 
death, although there are some differences in survival rates. It is 
still unclear which kind of relation is especially beneficial for health, 
but it is clear that all sorts of relations – ranging from neighbours till 
family members – are advantageous for health outcomes. Important 
in this is also the role of reciprocity; giving support seems to be at 
least as beneficial for health as receiving support. It appears even 
that as Stoller formulates it “the inability to reciprocate rather than 
the need for assistance undermines the morale of the older person”. 
These findings are consistent with the so-called ‘altruism theory’; 
a theory that claims that giving also brings important benefits. 
Informal care and frequent social contact then emerge as important 
for the health of older people both because of the decreased feelings 
of isolation it provides as well as the opportunity it entails to reci-
procate for the older person. 
The question still remains on whom the responsibility for care in 
Japan lies. In Japan, research has shown that the most dependable 
source for both instrumental and emotional support were family 
members living together, followed by children living apart, and 
neighbours and friends. Clearly the responsibility for care in Japan 
relies first and foremost on the direct family members of older 
people. This is especially the case for long-term care. In addition 
family members living together seem a more stable source of support 
as their support has been found to be independent of functional 
status, health status or educational background of the older person 
involved. In the Netherlands, this situation seems different. Rather 
than a source for instrumental support, family members seem to 
be more a source for emotional support. As Mrs. F. also indicated, 
elderly in the Netherlands in general have a strong will to remain 
independent and not to be ‘burdensome’ to their family members. 
This in contrast to Japan where the expectation of filial piety 
(oyakoko) is still important, even if it has been decreasing in 
importance somewhat in recent years.
3.4 Co-residence
If we compare Japan and the Netherlands in terms of family relation-
ships, it is well known that in Japan it is more common to live with 
several generations in one house. Geographic proximity is not a 
direct indicator of emotional and instrumental support, but might 
increase the likelihood of functional support and social contact by 
the sheer principle of availability. Moreover, this is an especially 
important aspect because, as we have noted above, family members 
that live together are a stable source of support.
In 2007 44% of the Japanese elderly (65 years and older) lived with 
their children. In addition a large number of elderly live with their 
children on the same site. In 2001 co-residence for instance – inclu-
ding living on the same site – amounted to 68%. Co-residence is 
relatively decreasing in recent years though, although a 65-year old 
in Japan is still far more likely to be living with a child than in other 
industrial societies. Compared to the Netherlands there is a striking 
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difference. According to the OECD, in 2002, only 6% of women aged 
65 years and older lived with their children, and for men this was 
slightly higher with about 8%.
Our question then whether the responsibility for care in Japan is 
beneficial for life expectancy at older ages, cannot be answered 
directly. The responsibility for instrumental care clearly lies more with 
family members in Japan than in the Netherlands, but it is not directly 
evident if this might be a piece of the puzzle why Japan is doing so 
well in terms of life expectancy. It is apparent, however, that the 
expectation is that family members take care of elderly. Due to this 
and the higher rate of adults living with their parents, Japanese 
elderly simply have social contact  more frequently. Adding to this 
that in Japan instrumental support is more important than emotional 
support (and vice versa for the Netherlands) it is tempting to specu-
late whether these two facets potentially benefit the survival rates of 
older people.
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Especially for women, even after correction for differences in expected 
historical smoking prevalence, Dutch women can still expect to live 
two years less than Japanese women. Since the increased mortality 
cannot be attributed to a specific group of diseases, an emerging 
hypothesis is that more general, socio-medical determinants could be 
behind the shorter life expectancy.
The Netherlands has seen large societal changes over the past 
50 years. At first sight, a shift in responsibility for care of older 
people has taken place from familial and informal care to institutio-
nalised care. As a result one easily comes to the conclusion that the 
Netherlands is one of the countries with one of the highest rates of 
institutionalised care in the world. However, this is not the case. In 
this report we have compared Japanese elderly care with the situation 
in the Netherlands. Japan, usually praised for its low rates of instituti-
onalised care, in fact has a similar rate of institutionalisation if one 
takes into account the long-term stay of older people in hospitals.
It is therefore in the last part of this report that we have performed 
an initial exploration of social relations and informal care in Japan 
and the Netherlands. Although it is too early to draw any hard 
conclusions, there are indirect indications that social support is 
different in Japan and perhaps more beneficial at older age, than in 
the Netherlands. In the Netherlands giving instrumental support is 
less expected than giving emotional support. This might have its 
effects on the degree of informal care as well. It seems that the 
separation of kinds of support is less prone for family members in 
Japan and especially giving instrumental help is expected. In Japan 
therefore, older people might benefit from the idea that giving 
instrumental help is expected from their adult children as this might 
lead to higher levels of informal care that includes physical and 
functional care. In the Netherlands social relations concentrate much 
more on emotional support. This last kind of support might be less 
favourable for older people as they feel less inclined to ask or receive 
Dutch life expectancy has not improved as much 
as in other countries over the past 50 years. 
This stagnation is mainly due to stagnation in 
the decline of the mortality rate of the age-group 
65 years and above. For Dutch men of 65 years 
and older this can be largely explained by 
the high expected historic prevalence of smoking 
in the Netherlands. Smoking, however, does not 
explain the entire period of stagnation of life 
expectancy in the Netherlands.
Discussion
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In conclusion, in this report we have explored several hypotheses 
that might explain the stagnation of life expectancy in the Nether-
lands and the outstanding record of the Japanese. First we explored 
several, often postulated, hypotheses but these were ruled out. 
We have found that smoking, especially for women, only explains 
part of the differences between the countries. We have continued 
our exploration with the next hypothesis that a high rate of institu-
tionalisation might be contributing to the Dutch stagnation. We ruled 
this hypothesis out and this led us to argue that several more indirect 
causes might be the source of Japan’s good standing. Our next 
hypothesis therefore turned towards informal care and social support. 
Here we found some differences: in Japan instrumental support of 
family members is more accepted and expected, and co-residence 
is more present than in the Netherlands. More research is needed to 
fully establish the impact of this difference. It is also possible that 
if we research this in-depth that this is not the whole answer to our 
dilemma of life expectancy. 
It is necessary to continue the falsification of hypotheses and to 
expand this research towards other factors. Often proposed alterna-
tive explanations include nutrition, but direct evidence of the relation 
between nutrition and life expectancy is still lacking. Especially when 
it comes to what kind of nutrition is favourable for life expectancy 
evidence is inconclusive. Also there are some major differences in 
the organisation and financing of health care in Japan and the 
Netherlands. The Japanese system might be more equipped for older 
people and this might have its effects on life expectancy at age 65 
and above. Physical activity is another key that is worthwhile to 
explore in the case of Japan. There is a large body of evidence that 
physical activity increases the number of years living in good health 
and free of cardiovascular disease. Moreover it contributes to a 
slower decline in mobility performance. There is already some 
evidence that current physical activity – and not only past activity – 
seems to be more important for mortality risk. This might be an 
instrumental support of family members. An explanation for 
this phenomenon might be found in the different descent kinship 
systems; Japan has a descent kinship system in which as Nauck 
and Suckow have concluded “instrumental relations determine the 
character of intergenerative and kinship relations.” In contrast, 
the Dutch kinship system can be characterised as having a primacy 
of conjugal relations in which instrumental help is given less whereas 
expressivity (emotions) in family relations is larger. 
Patterns of informal and formal care are also influenced by descent 
systems in another way, namely by the Japanese patrilineal and 
patrilocal tradition. Being patrilocal by tradition also results in a 
higher amount of co-residence, especially with oldest sons, and more 
often than not adult children live close to their parents. Familial care, 
as a logical extension of this tradition, is provided by the daughters-
in-law or unmarried daughters. This in contrast to affinal kinship, 
present for instance in Germany and the Netherlands, where the 
conjugal relationships have higher importance and thus expectations 
of co-residence and informal care are different. Moreover the high 
rate of co-residence might influence instrumental care because family 
members living together have been found to be a stable source of 
support. These aspects might contribute to health benefits as we 
have seen in previous research.
Finally, being a caretaker in Japan is still an accepted career-pathway 
for women, this in contrast to women in many other countries. 
American female care-givers for example usually perceive care-giving 
as a break, especially career-wise, whereas in Japan this is much less 
the case. These factors of support expectations, co-residence and 
caretaker perspectives might on the one hand together contribute to 
a larger availability of social contacts in Japan and a more accepted 
inclination to give instrumental support on the other hand.
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important hypothesis to explain the differences in life expectancy 
as data indicates that in Japan the elderly actually physically exercise 
more after age 65 than at middle ages in Japan, whereas in the 
Netherlands the trend seems to be that older people do less physical 
exercise after age 65 compared to the middle age-group.
 
Japan shows us that Dutch life expectancy can still be improved. 
This indicates that there is plasticity in life expectancy and this is 
in fact a hopeful message. It is the future challenge to find out how 
exactly to improve Dutch life expectancy and especially life expec-
tancy after age 65. Improvements that benefit older people will one 
day benefit us all.
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On the 10th of November 2009 we discussed the differences in life 
expectancy between the developed countries. During the meeting, all 
four countries were successively discussed.  From each country both 
a demographer and a clinician were asked to reflect on the develop-
ment of life expectancy of their countries over the past 50 years and 
to reflect on the stagnation of the Dutch life expectancy. 
On 11 November we discussed an earlier version of this report. We 
came to the following conclusions that all participants could agree 
upon:
• In general, longer life spans go with longer lives with good quality.
• Abstention from smoking is an obvious target to get more out of 
 our lives.
• The ability to better manage chronic diseases is a first step of 
 progress.
• Life expectancy, disability and quality of life are distinct concepts 
 and may have different determinants.
• Differences in smoking behaviour is part of the explanation why life 
 expectancy in most countries is lagging behind the average life
 expectancy of Japan.
• Too little is known of mortality in the oldest old to fully understand 
 the differences between life expectancy between countries.
• Factors that determine changes in life expectancy over time may 
 differ from determinants that rank countries on their life expectancy.
 
Leyden Academy on Vitality and Ageing, in 
collaboration with The Netherlands 
Interdisciplinary Demographic Institute (NIDI) 
organised an international expert meeting on 
10 and 11 November 2009 under the title: 
‘Dutch life expectancy in international perspective’. 
This meeting was also attended by demographers 
and representatives of the International Longevity 
Centers of four countries under study; 
the Netherlands, the United States, France 
and Japan.
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comparison project on life expectancy and ageing between the 
Netherlands, France, the United States and Japan. This programme is 
carried out in cooperation with various international universities and 
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in conjunction with the period of stagnation in the decline of morta-
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stand the factors that have led to this stagnation of life expectancy. 
In this exploration it aims to come to insights that might improve the 
situation in the Netherlands. It hopes to achieve part of this improve-
ment by placing both research and attention for ageing, vitality and 
life expectancy at the heart of the political and scientific agenda in 
the Netherlands. Besides this, the institute will identify possible 
causes of this stagnation that needs to be further researched and 
examined. This is grounded in high academic standards and with an 
international orientation.
The main goals are to achieve an analysis of international differences 
in life expectancy and healthcare and to identify new topics for 
research to improve both the health and care for the elderly.
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The Leyden Academy on Vitality and Ageing is a 
knowledge centre with an education and research 
programme in the field of ageing, vitality and 
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master students and professionals, given by leading 
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to advance the quality of life of older people.
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